nodes	percent_of_prediction	percent_of_DWPC	metapath
Brompheniramine—CHRM3—nephrolithiasis	0.898	1	CbGaD
Brompheniramine—CHRM3—ureter—nephrolithiasis	0.013	0.33	CbGeAlD
Brompheniramine—CHRM4—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00661	0.11	CbGpPWpGaD
Brompheniramine—CHRM5—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00633	0.106	CbGpPWpGaD
Brompheniramine—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00446	0.0745	CbGpPWpGaD
Brompheniramine—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.0044	0.0735	CbGpPWpGaD
Brompheniramine—CYP2C19—urine—nephrolithiasis	0.00393	0.0996	CbGeAlD
Brompheniramine—CYP2C9—urine—nephrolithiasis	0.00305	0.0773	CbGeAlD
Brompheniramine—CYP2E1—urine—nephrolithiasis	0.00289	0.0732	CbGeAlD
Brompheniramine—CYP3A4—urine—nephrolithiasis	0.00232	0.0589	CbGeAlD
Brompheniramine—CYP2D6—urine—nephrolithiasis	0.00229	0.058	CbGeAlD
Brompheniramine—Tolterodine—CHRM3—nephrolithiasis	0.00185	0.701	CrCbGaD
Brompheniramine—CHRM4—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00146	0.0244	CbGpPWpGaD
Brompheniramine—CHRM5—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0014	0.0234	CbGpPWpGaD
Brompheniramine—CHRM4—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00123	0.0205	CbGpPWpGaD
Brompheniramine—CHRM5—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00118	0.0197	CbGpPWpGaD
Brompheniramine—CHRM3—renal system—nephrolithiasis	0.00103	0.0262	CbGeAlD
Brompheniramine—CHRM3—kidney—nephrolithiasis	0.001	0.0254	CbGeAlD
Brompheniramine—HRH1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000989	0.0165	CbGpPWpGaD
Brompheniramine—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000985	0.0165	CbGpPWpGaD
Brompheniramine—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.000973	0.0163	CbGpPWpGaD
Brompheniramine—KCNH2—renal system—nephrolithiasis	0.000917	0.0233	CbGeAlD
Brompheniramine—CHRM4—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000896	0.015	CbGpPWpGaD
Brompheniramine—CHRM5—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000858	0.0143	CbGpPWpGaD
Brompheniramine—CYP2C8—renal system—nephrolithiasis	0.000839	0.0213	CbGeAlD
Brompheniramine—HRH1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000831	0.0139	CbGpPWpGaD
Brompheniramine—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000828	0.0138	CbGpPWpGaD
Brompheniramine—CYP2B6—nephron tubule—nephrolithiasis	0.000828	0.021	CbGeAlD
Brompheniramine—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.000818	0.0137	CbGpPWpGaD
Brompheniramine—CYP2C8—kidney—nephrolithiasis	0.000811	0.0206	CbGeAlD
Brompheniramine—Promazine—CHRM3—nephrolithiasis	0.000788	0.299	CrCbGaD
Brompheniramine—CYP2E1—nephron tubule—nephrolithiasis	0.000777	0.0197	CbGeAlD
Brompheniramine—CYP2B6—renal system—nephrolithiasis	0.000753	0.0191	CbGeAlD
Brompheniramine—CYP2B6—kidney—nephrolithiasis	0.000728	0.0185	CbGeAlD
Brompheniramine—CYP2E1—renal system—nephrolithiasis	0.000707	0.0179	CbGeAlD
Brompheniramine—CYP2E1—kidney—nephrolithiasis	0.000683	0.0173	CbGeAlD
Brompheniramine—CYP2E1—cortex of kidney—nephrolithiasis	0.000665	0.0169	CbGeAlD
Brompheniramine—CHRM4—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000622	0.0104	CbGpPWpGaD
Brompheniramine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000604	0.0101	CbGpPWpGaD
Brompheniramine—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000602	0.0101	CbGpPWpGaD
Brompheniramine—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000596	0.00996	CbGpPWpGaD
Brompheniramine—CYP3A4—renal system—nephrolithiasis	0.000569	0.0144	CbGeAlD
Brompheniramine—CYP2D6—renal system—nephrolithiasis	0.000559	0.0142	CbGeAlD
Brompheniramine—CYP3A4—kidney—nephrolithiasis	0.00055	0.0139	CbGeAlD
Brompheniramine—CYP2D6—kidney—nephrolithiasis	0.000541	0.0137	CbGeAlD
Brompheniramine—CHRM5—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000483	0.00807	CbGpPWpGaD
Brompheniramine—CHRM4—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000438	0.00731	CbGpPWpGaD
Brompheniramine—CHRM4—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000438	0.00731	CbGpPWpGaD
Brompheniramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000432	0.00722	CbGpPWpGaD
Brompheniramine—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000432	0.00722	CbGpPWpGaD
Brompheniramine—CHRM5—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000419	0.007	CbGpPWpGaD
Brompheniramine—CHRM5—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000419	0.007	CbGpPWpGaD
Brompheniramine—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000414	0.00692	CbGpPWpGaD
Brompheniramine—CYP2B6—Biological oxidations—SLC26A1—nephrolithiasis	0.00035	0.00585	CbGpPWpGaD
Brompheniramine—CHRM5—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000349	0.00584	CbGpPWpGaD
Brompheniramine—CYP2E1—Biological oxidations—SLC26A1—nephrolithiasis	0.000343	0.00573	CbGpPWpGaD
Brompheniramine—HRH1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000341	0.0057	CbGpPWpGaD
Brompheniramine—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00034	0.00569	CbGpPWpGaD
Brompheniramine—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000339	0.00567	CbGpPWpGaD
Brompheniramine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000312	0.00522	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000305	0.0051	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000304	0.00508	CbGpPWpGaD
Brompheniramine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000303	0.00507	CbGpPWpGaD
Brompheniramine—CYP2C8—Biological oxidations—SLC26A1—nephrolithiasis	0.000296	0.00495	CbGpPWpGaD
Brompheniramine—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000295	0.00493	CbGpPWpGaD
Brompheniramine—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000295	0.00493	CbGpPWpGaD
Brompheniramine—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000291	0.00487	CbGpPWpGaD
Brompheniramine—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000291	0.00487	CbGpPWpGaD
Brompheniramine—CHRM4—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000282	0.00471	CbGpPWpGaD
Brompheniramine—CHRM5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00027	0.00451	CbGpPWpGaD
Brompheniramine—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.000264	0.00442	CbGpPWpGaD
Brompheniramine—HRH1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000247	0.00412	CbGpPWpGaD
Brompheniramine—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000246	0.00411	CbGpPWpGaD
Brompheniramine—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.000243	0.00406	CbGpPWpGaD
Brompheniramine—CHRM4—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000242	0.00404	CbGpPWpGaD
Brompheniramine—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.000241	0.00403	CbGpPWpGaD
Brompheniramine—CHRM5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000231	0.00387	CbGpPWpGaD
Brompheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000221	0.00369	CbGpPWpGaD
Brompheniramine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00022	0.00368	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—RGS14—nephrolithiasis	0.000213	0.00356	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—RGS14—nephrolithiasis	0.000204	0.00341	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—RGS14—nephrolithiasis	0.000193	0.00323	CbGpPWpGaD
Brompheniramine—HRH1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000191	0.00319	CbGpPWpGaD
Brompheniramine—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00019	0.00318	CbGpPWpGaD
Brompheniramine—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000188	0.00314	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.000185	0.00309	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR ligand binding—CHRM3—nephrolithiasis	0.000184	0.00307	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.000176	0.00294	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR ligand binding—PTH—nephrolithiasis	0.000168	0.00281	CbGpPWpGaD
Brompheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000163	0.00273	CbGpPWpGaD
Brompheniramine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000163	0.00272	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.000161	0.00269	CbGpPWpGaD
Brompheniramine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000161	0.00269	CbGpPWpGaD
Brompheniramine—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000159	0.00266	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000144	0.00241	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—DGKH—nephrolithiasis	0.000144	0.0024	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000144	0.0024	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000143	0.00239	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000142	0.00237	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.000138	0.0023	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ADCY10—nephrolithiasis	0.000134	0.00224	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—RGS14—nephrolithiasis	0.000131	0.00219	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—DGKH—nephrolithiasis	0.000131	0.00218	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.00013	0.00218	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.00013	0.00217	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000129	0.00215	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.000129	0.00215	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.000125	0.00209	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000124	0.00208	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.000124	0.00207	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000122	0.00205	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—RGS14—nephrolithiasis	0.000114	0.00191	CbGpPWpGaD
Brompheniramine—HRH1—GPCR ligand binding—PTH—nephrolithiasis	0.000114	0.0019	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000113	0.0019	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000113	0.00189	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000112	0.00187	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.000109	0.00183	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000104	0.00174	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	9.96e-05	0.00166	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—DGKH—nephrolithiasis	9.73e-05	0.00163	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	9.7e-05	0.00162	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	9.67e-05	0.00162	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	9.57e-05	0.0016	CbGpPWpGaD
Brompheniramine—CHRM4—GPCR downstream signaling—PTH—nephrolithiasis	9.51e-05	0.00159	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—CHRM3—nephrolithiasis	9.44e-05	0.00158	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—GRHPR—nephrolithiasis	9.18e-05	0.00153	CbGpPWpGaD
Brompheniramine—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	9.11e-05	0.00152	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ADCY10—nephrolithiasis	9.09e-05	0.00152	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	9.06e-05	0.00151	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	9.04e-05	0.00151	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	9.03e-05	0.00151	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	8.94e-05	0.00149	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—DGKH—nephrolithiasis	8.83e-05	0.00148	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	8.81e-05	0.00147	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	8.78e-05	0.00147	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	8.69e-05	0.00145	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling by GPCR—PTH—nephrolithiasis	8.64e-05	0.00144	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	8.27e-05	0.00138	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AGXT—nephrolithiasis	8.18e-05	0.00137	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—GRHPR—nephrolithiasis	7.9e-05	0.00132	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—GRHPR—nephrolithiasis	7.74e-05	0.00129	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—RGS14—nephrolithiasis	7.73e-05	0.00129	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.72e-05	0.00129	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—DGKH—nephrolithiasis	7.72e-05	0.00129	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	7.7e-05	0.00129	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	7.68e-05	0.00128	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	7.6e-05	0.00127	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	7.39e-05	0.00123	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.39e-05	0.00123	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AGXT—nephrolithiasis	7.04e-05	0.00118	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—CHRM3—nephrolithiasis	7.03e-05	0.00118	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	7.01e-05	0.00117	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—SLC26A1—nephrolithiasis	6.96e-05	0.00116	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—APRT—nephrolithiasis	6.96e-05	0.00116	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	6.92e-05	0.00116	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AGXT—nephrolithiasis	6.9e-05	0.00115	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—GRHPR—nephrolithiasis	6.69e-05	0.00112	CbGpPWpGaD
Brompheniramine—HRH1—GPCR downstream signaling—PTH—nephrolithiasis	6.43e-05	0.00107	CbGpPWpGaD
Brompheniramine—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	6.41e-05	0.00107	CbGpPWpGaD
Brompheniramine—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	6.39e-05	0.00107	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—CHRM3—nephrolithiasis	6.39e-05	0.00107	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	6.37e-05	0.00106	CbGpPWpGaD
Brompheniramine—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	6.33e-05	0.00106	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	6.28e-05	0.00105	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—SLC26A1—nephrolithiasis	5.99e-05	0.001	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—APRT—nephrolithiasis	5.99e-05	0.001	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—GRHPR—nephrolithiasis	5.97e-05	0.000997	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AGXT—nephrolithiasis	5.96e-05	0.000996	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—SLC26A1—nephrolithiasis	5.86e-05	0.00098	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—APRT—nephrolithiasis	5.86e-05	0.00098	CbGpPWpGaD
Brompheniramine—HRH1—Signaling by GPCR—PTH—nephrolithiasis	5.84e-05	0.000976	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	5.82e-05	0.000973	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	5.8e-05	0.00097	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	5.75e-05	0.00096	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—CHRM3—nephrolithiasis	5.58e-05	0.000932	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—GRHPR—nephrolithiasis	5.49e-05	0.000917	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—GRHPR—nephrolithiasis	5.44e-05	0.000909	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	5.34e-05	0.000893	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AGXT—nephrolithiasis	5.32e-05	0.000889	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.22e-05	0.000872	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—DGKH—nephrolithiasis	5.22e-05	0.000872	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	5.2e-05	0.000869	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.2e-05	0.000869	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	5.19e-05	0.000866	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.19e-05	0.000866	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	5.14e-05	0.000858	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	5.14e-05	0.000858	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—PTH—nephrolithiasis	5.1e-05	0.000852	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—SLC26A1—nephrolithiasis	5.07e-05	0.000847	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—APRT—nephrolithiasis	5.07e-05	0.000847	CbGpPWpGaD
Brompheniramine—CHRM3—Metabolism—AQP1—nephrolithiasis	4.96e-05	0.000828	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AGXT—nephrolithiasis	4.89e-05	0.000818	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—PTH—nephrolithiasis	4.89e-05	0.000816	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AGXT—nephrolithiasis	4.85e-05	0.00081	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—APRT—nephrolithiasis	4.52e-05	0.000756	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	4.52e-05	0.000756	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—AQP1—nephrolithiasis	4.27e-05	0.000713	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—AQP1—nephrolithiasis	4.18e-05	0.000698	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—APRT—nephrolithiasis	4.16e-05	0.000695	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	4.16e-05	0.000695	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	4.12e-05	0.000689	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—APRT—nephrolithiasis	4.12e-05	0.000689	CbGpPWpGaD
Brompheniramine—CYP2B6—Metabolism—CHRM3—nephrolithiasis	3.86e-05	0.000644	CbGpPWpGaD
Brompheniramine—CYP2E1—Metabolism—CHRM3—nephrolithiasis	3.78e-05	0.000631	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—CHRM3—nephrolithiasis	3.77e-05	0.00063	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	3.76e-05	0.000628	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	3.71e-05	0.00062	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—AQP1—nephrolithiasis	3.61e-05	0.000603	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—GRHPR—nephrolithiasis	3.59e-05	0.0006	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—PTH—nephrolithiasis	3.45e-05	0.000577	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—PTH—nephrolithiasis	3.44e-05	0.000575	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—PTH—nephrolithiasis	3.43e-05	0.000573	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—PTH—nephrolithiasis	3.4e-05	0.000567	CbGpPWpGaD
Brompheniramine—CYP2C8—Metabolism—CHRM3—nephrolithiasis	3.27e-05	0.000546	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—AQP1—nephrolithiasis	3.22e-05	0.000539	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AGXT—nephrolithiasis	3.2e-05	0.000535	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—AQP1—nephrolithiasis	2.96e-05	0.000495	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—AQP1—nephrolithiasis	2.94e-05	0.000491	CbGpPWpGaD
Brompheniramine—CYP2C19—Metabolism—CHRM3—nephrolithiasis	2.91e-05	0.000487	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—APRT—nephrolithiasis	2.72e-05	0.000454	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	2.72e-05	0.000454	CbGpPWpGaD
Brompheniramine—CYP2D6—Metabolism—CHRM3—nephrolithiasis	2.68e-05	0.000448	CbGpPWpGaD
Brompheniramine—CYP2C9—Metabolism—CHRM3—nephrolithiasis	2.66e-05	0.000444	CbGpPWpGaD
Brompheniramine—CHRM4—Signaling Pathways—SPP1—nephrolithiasis	2.56e-05	0.000428	CbGpPWpGaD
Brompheniramine—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	2.45e-05	0.00041	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—AQP1—nephrolithiasis	1.94e-05	0.000324	CbGpPWpGaD
Brompheniramine—CYP3A4—Metabolism—CHRM3—nephrolithiasis	1.75e-05	0.000293	CbGpPWpGaD
Brompheniramine—HRH1—Signaling Pathways—SPP1—nephrolithiasis	1.73e-05	0.000289	CbGpPWpGaD
Brompheniramine—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	1.73e-05	0.000289	CbGpPWpGaD
Brompheniramine—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	1.72e-05	0.000288	CbGpPWpGaD
Brompheniramine—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	1.7e-05	0.000285	CbGpPWpGaD
